Peter Martin Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

6/2022	Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts.
11/2021	Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
9/2021	Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
6/2021	Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma?
3/2021	Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions.
3/2020	Targeting CDK4/6 in mantle cell lymphoma.
1/2020	An update on options of therapy for aggressive mantle cell lymphoma.
12/2019	A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.
1/2019	A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.
1/2019	To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Martin Research Topics

Disease

44	Neoplasms (Cancer) 01/2022 - 08/2007
35	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2022 - 03/2008
28	Lymphoma (Lymphomas) 12/2022 - 04/2008
18	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 07/2007
17	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2022 - 12/2008
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 07/2008
8	Cachexia 01/2022 - 01/2012
5	COVID-19 01/2022 - 11/2020
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 06/2013
4	Stroke (Strokes) 12/2022 - 07/2013
4	Fatigue 11/2017 - 01/2012
4	Inflammation (Inflammations) 01/2015 - 01/2004
3	Dementia (Dementias) 12/2022 - 09/2016
3	Death (Near-Death Experience) 01/2022 - 03/2013
3	Disease Progression 01/2022 - 11/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 12/2010
3	Schizophrenia (Dementia Praecox) 11/2004 - 02/2003
2	Parkinson Disease (Parkinson's Disease) 12/2022 - 09/2002
2	Chronic Disease (Chronic Diseases) 04/2021 - 03/2013
2	Weight Loss (Weight Reduction) 01/2021 - 01/2019
2	Anorexia 01/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 01/2012
2	Frailty 12/2020 - 09/2016
2	Nausea 05/2018 - 11/2017
2	Neutropenia 01/2017 - 03/2014
2	Hodgkin Disease (Hodgkin's Disease) 12/2015 - 06/2009
2	Diarrhea 08/2015 - 03/2014
2	Infections 08/2015 - 01/2004
2	Wounds and Injuries (Trauma) 07/2013 - 01/2004
1	Herpes Zoster 12/2022
1	Coronary Disease (Coronary Heart Disease) 12/2022
1	Cardiotoxicity 01/2022
1	Heart Failure 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021

Drug/Important Bio-Agent (IBA)

24	Rituximab (Mabthera)FDA Link 12/2022 - 09/2007
15	ibrutinibIBA 11/2020 - 08/2013
8	Bendamustine Hydrochloride FDA Link 12/2022 - 01/2017
8	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 08/2013
8	Prednisone (Sone)FDA LinkGeneric 04/2012 - 03/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2012 - 03/2008
7	Proteins (Proteins, Gene)FDA Link 11/2019 - 09/2002
6	Etoposide (VP 16)FDA LinkGeneric 12/2021 - 03/2008
6	Pharmaceutical PreparationsIBA 01/2021 - 05/2008
6	palbociclibIBA 03/2020 - 05/2012
5	idelalisibIBA 01/2021 - 06/2013
5	Lenalidomide (CC 5013)FDA Link 01/2020 - 11/2015
5	Bortezomib (Velcade)FDA Link 12/2019 - 12/2010
4	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2022 - 10/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2008
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
4	Monoclonal AntibodiesIBA 01/2015 - 09/2007
4	Procarbazine (Matulane)FDA Link 04/2012 - 03/2008
4	Vincristine (Oncovin)FDA LinkGeneric 02/2011 - 07/2008
3	Alkylating AgentsIBA 04/2022 - 03/2014
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 08/2012
3	AlbuminsIBA 01/2021 - 03/2004
3	Cyclin D1IBA 03/2020 - 06/2013
3	N-Methylaspartate (NMDA)IBA 11/2004 - 02/2003
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2004 - 02/2003
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 01/2016
2	selinexorIBA 12/2021 - 01/2017
2	Ifosfamide FDA LinkGeneric 12/2021 - 08/2012
2	acalabrutinibIBA 01/2021 - 01/2020
2	Proteasome InhibitorsIBA 12/2019 - 02/2011
2	AntiemeticsIBA 05/2018 - 03/2008
2	Biological ProductsIBA 07/2017 - 10/2008
2	tositumomab I-131 (Bexxar)FDA Link 02/2015 - 06/2010
2	milatuzumabIBA 01/2015 - 01/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 06/2010
2	Phosphopyruvate Hydratase (Enolase)IBA 03/2004 - 02/2003
2	Adenosine Triphosphate (ATP)IBA 03/2004 - 02/2003
1	Apolipoproteins E (ApoE)IBA 12/2022
1	ApolipoproteinsIBA 12/2022
1	cc-486IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	2-toluenesulfonamide (OTS)IBA 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 12/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	Multiprotein ComplexesIBA 10/2021
1	Immunomodulating AgentsIBA 06/2021
1	Phosphotransferases (Kinase)IBA 06/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021

Therapy/Procedure

43	Therapeutics 12/2022 - 07/2007
13	Drug Therapy (Chemotherapy) 12/2021 - 01/2004
6	Palliative Care (Palliative Therapy) 04/2021 - 03/2013
4	Activities of Daily Living (ADL) 01/2019 - 01/2012
4	Combination Drug Therapy (Combination Chemotherapy) 12/2015 - 03/2008
3	Ambulatory Care (Outpatient Care) 01/2021 - 11/2020
3	Stem Cell Transplantation 01/2021 - 06/2010
2	Transplantation 06/2022 - 09/2002
2	Home Nursing (Nursing, Home) 01/2022 - 09/2016
2	Biological Therapy 01/2021 - 11/2015
2	Immunotherapy 01/2020 - 01/2019
2	Aftercare (After-Treatment) 01/2017 - 06/2009
2	Terminal Care (Care, Terminal) 07/2015 - 03/2013
2	Radioimmunotherapy 02/2015 - 01/2015
2	Splenectomy 02/2012 - 04/2008
1	Time-to-Treatment 05/2021